IP Library Granted Patent US 8,338,170
Granted Patent B2
US 8,338,170 · App. 12/107,020 · Granted Dec 25, 2012

Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells

Assignee: Viacyte, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,338,170
App. No.
12/107,020
Granted
Dec 25, 2012
Kind
B2
Abstract

The present disclosure relates to compositions and methods comprising cell surface markers for hES-derived cells, in particular, endoderm lineage cells including pancreatic endoderm-type cells, derived from hES cells.

Claims (8)

1. A method of enriching for cells expressing pancreatic and duodenal homeobox gene 1 (PDX1) comprising:

a) exposing an in vitro cell population comprising PDX1 positive pancreatic cells to a ligand that binds CD142; and

b) selecting cells that express CD142 thereby enriching for cells expressing PDX1.

2. The method of claim 1 , wherein said PDX1 positive cells express NKX6.1.

3. The method of claim 1 , wherein the ligand comprises an antibody or binding fragment thereof.

4. The method of claim 1 , wherein said ligand is associated with a detectable label.

5. The method of claim 1 , wherein said ligand is associated with a magnetic particle.

6. The method of claim 1 , wherein said cells are selected by Fluorescence Activated Cell Sorting (FACS).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2013
From: KELLY, OLIVIA; BANG, ANNE
To: VIACYTE, INC.
Reel/Frame 029898/0305 →
Continuity (1)
Related Publication 20090263896A1 · Oct 22, 2009